BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31645677)

  • 1. EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins.
    Fitzsimmons L; Cartlidge R; Chang C; Sejic N; Galbraith LCA; Suraweera CD; Croom-Carter D; Dewson G; Tierney RJ; Bell AI; Shannon-Lowe C; Herold MJ; Rickinson AB; Colman PM; Huang DCS; Strasser A; Kvansakul M; Rowe M; Kelly GL
    Cell Death Differ; 2020 May; 27(5):1554-1568. PubMed ID: 31645677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1.
    Kvansakul M; Wei AH; Fletcher JI; Willis SN; Chen L; Roberts AW; Huang DC; Colman PM
    PLoS Pathog; 2010 Dec; 6(12):e1001236. PubMed ID: 21203485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.
    Watanabe A; Maruo S; Ito T; Ito M; Katsumura KR; Takada K
    J Virol; 2010 Mar; 84(6):2893-901. PubMed ID: 20042495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal Structures of Epstein-Barr Virus Bcl-2 Homolog BHRF1 Bound to Bid and Puma BH3 Motif Peptides.
    Suraweera CD; Hinds MG; Kvansakul M
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
    Kelly GL; Long HM; Stylianou J; Thomas WA; Leese A; Bell AI; Bornkamm GW; Mautner J; Rickinson AB; Rowe M
    PLoS Pathog; 2009 Mar; 5(3):e1000341. PubMed ID: 19283066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization and preliminary X-ray characterization of Epstein-Barr virus BHRF1 in complex with a benzoylurea peptidomimetic.
    Caria S; Chugh S; Nhu D; Lessene G; Kvansakul M
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Dec; 68(Pt 12):1521-4. PubMed ID: 23192038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cellular protein VRK2 interacts specifically with Epstein-Barr virus BHRF1, a homologue of Bcl-2, and enhances cell survival.
    Li LY; Liu MY; Shih HM; Tsai CH; Chen JY
    J Gen Virol; 2006 Oct; 87(Pt 10):2869-2878. PubMed ID: 16963744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epstein-Barr virus gene BHRF1, a homologue of the cellular oncogene Bcl-2, inhibits apoptosis induced by gamma radiation and chemotherapeutic drugs.
    McCarthy NJ; Hazlewood SA; Huen DS; Rickinson AB; Williams GT
    Adv Exp Med Biol; 1996; 406():83-97. PubMed ID: 8910674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.
    Hui KF; Leung YY; Yeung PL; Middeldorp JM; Chiang AK
    Br J Haematol; 2014 Dec; 167(5):639-50. PubMed ID: 25155625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates.
    Khanim F; Dawson C; Meseda CA; Dawson J; Mackett M; Young LS
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():2987-99. PubMed ID: 9367386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2.
    Huang Q; Petros AM; Virgin HW; Fesik SW; Olejniczak ET
    J Mol Biol; 2003 Oct; 332(5):1123-30. PubMed ID: 14499614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim.
    Desbien AL; Kappler JW; Marrack P
    Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5663-8. PubMed ID: 19293378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.
    Leao M; Anderton E; Wade M; Meekings K; Allday MJ
    J Virol; 2007 Jan; 81(1):248-60. PubMed ID: 17035311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BHRF1 exerts an antiapoptotic effect and cell cycle arrest via Bcl-2 in murine hybridomas.
    Milián E; Prats E; Cairó JJ; Gòdia F; Vives J
    J Biotechnol; 2015 Sep; 209():58-67. PubMed ID: 26057602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins.
    Foight GW; Keating AE
    J Mol Biol; 2015 Jul; 427(15):2468-2490. PubMed ID: 26009469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1.
    Matsuda G; Nakajima K; Kawaguchi Y; Yamanashi Y; Hirai K
    Microbiol Immunol; 2003; 47(1):91-9. PubMed ID: 12636258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the Epstein-Barr virus BHRF1 gene, a homologue of Bcl-2, in nasopharyngeal carcinoma tissue.
    Liu MY; Shih YY; Li LY; Chou SP; Sheen TS; Chen CL; Yang CS; Chen JY
    J Med Virol; 2000 Jun; 61(2):241-50. PubMed ID: 10797381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpesvirus papio encodes a functional homologue of the Epstein-Barr virus apoptosis suppressor, BHRF1.
    Meseda CA; Arrand JR; Mackett M
    J Gen Virol; 2000 Jul; 81(Pt 7):1801-5. PubMed ID: 10859386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoma cells lacking pro-apoptotic BAX are highly resistant to BH3-mimetics targeting pro-survival MCL-1 but retain sensitivity to conventional DNA-damaging drugs.
    Diepstraten ST; Young S; La Marca JE; Wang Z; Kluck RM; Strasser A; Kelly GL
    Cell Death Differ; 2023 Apr; 30(4):1005-1017. PubMed ID: 36755070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression.
    Mérino D; Strasser A; Bouillet P
    Oncogene; 2012 Jul; 31(28):3392-6. PubMed ID: 22081075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.